Background

Dr. Jeffrey Himawan, also known as Jeff, Ph.D. serves as Managing Director of Essex Woodlands Health Ventures VII, L.P. Dr. Himawan joined Essex Woodlands Health Ventures, L.P., a venture capital firm. Dr. Himawan has been Managing Director of Essex Woodlands Health Ventures since 2004, where he was an Adjunct Partner since 1999 and Partner since 2001. Dr. Himawan was a Co-founder and Managing Director of Seed-One Ventures, LLC from 1996 to 2001. He Founded Elusys Therapeutics, ... Inc. From 1983 to 1996, Dr. Himawan was a Scientist in academic and industrial settings. He has been the Chairman of MediciNova Inc. since March 30, 2007 and has been its Director since January 2006. He has experience in the investment community. He served as the Chairman of Light Sciences Oncology, Inc. since December 2005 and has been its Director since September 2005. He serves as a Director of Symphogen A/S, Symphogen, Inc. and Ception Therapeutics, Inc. He has been a Director of Catalyst Biosciences, Inc. since December 2008 and Horizon Pharma plc since March 2010. He served as a Director of Sensatex Inc. and Receptor BioLogix, Inc. He served as a Director of Intercell USA, Inc. since December 2002. Dr. Himawan served as a Director of Iomai Corporation from 2001 to 2007. Dr. Himawan has B.S. in Biology from the Massachusetts Institute of Technology and has a Doctorate in Biological Chemistry and Molecular Pharmacology from Harvard University.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.